The global Prescription Lens Market is projected to grow from USD 54.0 billion in 2024 to USD 88.0 billion by 2033 at a CAGR of 5.3%, driven by rising vision impairment prevalence, advanced lens technologies, and expanding distribution channels.
The market’s growth is leveraging an increase in the aging population worldwide for its benefits. Bifocal, trifocal, and progressive lenses see their demand get louder due to presbyopia affecting a large section of the population in developed regions like North America and Europe. With increased awareness regarding eye health and better access to vision care services in emerging markets, the pool of prescription eyewear customers has increased more than ever, strengthening the landscape of the optical lenses industry.
